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Abstract (min: 200 words) 
Self-assembled peptide-based hydrogels have been shown promising properties for various 
applications, including resonance imaging and drug delivery. Here, the hydrogels’ molecules 
self-assemble into intertwined fibrillar structures through the cooperative effect of different 
non-covalent intra- and intermolecular interactions. Particularly, the peptide-based hydrogels 
are highly advantageous as nanocarriers for antitumour drug delivery owing to the low critical 
gelation concentration, amenable synthesis and structural tailoring of the rheological 
properties, as well as the biocompatibility and similarity to the extracellular matrix.  
Lately, wider developments in the use of peptide-based supramolecular hydrogels with 
optimum drug delivery and mechanical properties in biomedical research and clinical 
translation are hampered by the limited commercial availability and prohibitive costs.  
Hereby, considering the structural aspects that influence the assembly of peptide-based 
hydrogelators, a library of Cbz-protected dehydrodipeptides was synthesised and evaluated as 
minimalist hydrogels. The molecular aggregation, self-assembly, gelation and biocompatibility 
were thoroughly studied through fluorescence spectroscopy, and the mechanical properties 
were assessed. The compounds that afforded hydrogels were evaluated as drug delivery 
systems for curcumin and doxorubicin using biomembrane models. The hydrogels displayed 
similar properties to more complex supramolecular hydrogels. Moreover, the expeditious and 
scalable synthesis using amenable reaction conditions makes the Cbz-protected 
dehydrodipeptide hydrogels available at affordable cost to the research community. 
  
